Results 1 to 10 of about 139,988 (355)

Proton-pump inhibitors

South African Family Practice, 2015
Proton-pump inhibitors (PPIs) are a class of drugs that profoundly suppress gastric acid secretion, and thus have become the treatment of choice for gastro-oesophageal reflux disease and peptic ulcer disease. PPIs are considered safe and effective. It is
Vasudevan G. Naidoo
doaj   +4 more sources

Hypocalcemia After Thyroidectomy in Patients Taking Proton Pump Inhibitors [PDF]

Laryngoscope Investigative Otolaryngology
Objective Calcium homeostasis is regulated by the effects of parathyroid hormone (PTH) and vitamin D on the bones, GI tract, and kidneys. Post‐thyroidectomy hypoparathyroidism and resultant hypocalcemia are common complications associated with prolonged ...
Maxwell Rossip, F. Jeffrey Lorenz, Neerav Goyal, David Goldenberg   +3 more
doaj   +2 more sources

Deprescribing proton pump inhibitors

Singapore Medical Journal, 2023
Kim Jun Kevin Teh, Hai Kiat Troy Puar, Choon How How, Teck Kiang Malcolm Tan   +3 more
doaj   +3 more sources

Proton pump inhibitors and hypomagnesemia monitoring

International Journal of General Medicine, 2013
Thomas I LemonInstitute of Medical Education, Cardiff University School of Medicine, Cardiff, UKI thank El-Charabaty et al1 for their interesting paper which concludes that patients in receipt of proton pump inhibitors (PPIs) need to be followed closely ...
Lemon TI
doaj   +6 more sources

Safety of proton pump inhibitors [PDF]

Alimentary Pharmacology & Therapeutics, 2000
Helge L. Waldum, Eiliv Brenna, Tom Chr. Martinsen   +2 more
openalex   +4 more sources

Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors

Chonnam medical journal, 2023
Proton Pump Inhibitors are used widely to manage many gastric acid-related conditions such as gastroesophageal disease, gastritis, esophagitis, Barrett’s esophagus, Zollinger-Ellison syndrome, peptic ulcer disease, nonsteroidal anti-inflammatory drug ...
N. Maideen
semanticscholar   +1 more source

AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.

Gastroenterology, 2022
DESCRIPTION Proton pump inhibitors (PPIs) are among the most commonly used medications in the world. Developed for the treatment and prevention of acid-mediated upper gastrointestinal conditions, these agents are being used increasingly for indications ...
L. Targownik, D. Fisher, S. Saini
semanticscholar   +1 more source

Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis

Cancers, 2022
Simple Summary The current meta-analysis highlighted that proton pump inhibitors (PPIs) and histamine-2-receptor antagonists (H2RAs) could impact immune checkpoint inhibitors (ICIs) efficacy in NSCLC patients, highlighting the need for a deeper ...
Alessandro Rizzo, A. Cusmai, Francesco Giovannelli, Silvana Acquafredda, L. Rinaldi, A. Misino, E. Montagna, Valentina Ungaro, Mariagrazia Lorusso, G. Palmiotti   +9 more
semanticscholar   +1 more source

Multimorbidities and Overprescription of Proton Pump Inhibitors in Older Patients. [PDF]

PLoS ONE, 2015
To determine whether there is an association between overprescription of proton pump inhibitors (PPIs) and multimorbidities in older patients.Multicenter prospective study.Acute geriatric medicine at the University Hospital of Nantes and the Hospital of ...
Anne Delcher, Sylvie Hily, Anne Sophie Boureau, Guillaume Chapelet, Gilles Berrut, Laure de Decker   +5 more
doaj   +1 more source

Proton pump inhibitors and risk of gastric cancer: population-based cohort study

Gut, 2021
Objective To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of gastric cancer compared with new users of histamine-2 receptor antagonists (H2RAs).
D. Abrahami, E. McDonald, M. Schnitzer, A. Barkun, S. Suissa, L. Azoulay   +5 more
semanticscholar   +1 more source